25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      In vitro maturation of human immature oocytes for fertility preservation and research material

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aim

          In recent years, the importance of fertility preservation ( FP) has increased. In vitro maturation ( IVM), an important technique in FP, has started to be used in the clinic, but controversies persist regarding this technique. Here, a survey of IVM for FP is provided.

          Methods

          Based on a literature review, the applications of FP, methods of FP, IVM of oocytes that had been collected in vivo and ex vivo, maturation of oocytes after IVM for FP, cryopreservation of oocytes for FP, explanation of the procedures to patients, and recent research on FP using IVM were investigated.

          Results

          Although IVM for FP remains controversial, the application of FP is expected to expand. Depending on the age and disease status of the patient, various methods of oocyte collection and ovarian stimulation, as well as various needle types and aspiration pressures, have been reported. The maturation rate of IVM in FP ranges widely and requires optimization in the future. In regard to cryopreservation for matured oocytes, the vitrification method is currently recommended.

          Conclusion

          Regarding FP for patients with cancer, the treatment of cancer is prioritized; thus, the time and use of medicines are often constrained. As several key points regarding IVM remain unclear, well‐designed and specific counseling for patients is necessary.

          Related collections

          Most cited references89

          • Record: found
          • Abstract: found
          • Article: not found

          Oocyte vitrification as an efficient option for elective fertility preservation.

          To provide a detailed description of the current oocyte vitrification status as a means of elective fertility preservation (EFP).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children.

            This study aims to make an account of the children born following transplantation of frozen-thawed ovarian tissue worldwide with specific focus on the perinatal outcome of the children. Furthermore, perinatal outcome of seven deliveries (nine children) from Denmark is reported.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients.

              To determine the maturational and developmental competence of immature oocytes recovered in situ from anovulatory and ovulatory patients with polycystic ovaries (PCO). A newly designed method for recovery of immature oocytes from 2 to 10 mm follicles by transvaginal ultrasound or laparoscopy was used to compare the recovery and maturation of oocytes from 9 anovulatory polycystic ovarian syndrome (PCOS) patients and 10 ovulatory patients without polycystic ovaries (PCO) (experiment 1). In a second study (experiment 2), we compared the maturation, fertilization, and development of oocytes recovered from another 10 anovulatory PCOS and 13 ovulatory PCO patients. Two types of culture methods and time intervals for maturation were also examined. In experiment 1, a significantly higher number of immature oocytes were recovered from PCOS patients (15.3) compared with non-PCO patients (2.8). Sixty-five percent of oocytes cultured in medium with gonadotropins, estrogen, and fetal calf serum matured to metaphase II by 43 to 47 hours, and 81% were mature at 48 to 54 hours of culture. Thirty-four percent of the inseminated oocytes fertilized and 56% of the cultured pronuclear oocytes cleaved to eight cells or more. In experiment 2, there was no significant difference between anovulatory PCOS and ovulatory PCO patients in the number of oocytes recovered or their maturation, fertilization, and development. There was no difference between oocytes matured in medium or in coculture with mature granulosa cells, with or without added hCG. However, significantly fewer oocytes were immature and more fertilized when oocytes were inseminated after 34.5 to 35.5 hours of maturation than 29.5 to 32.5 hours of maturation. A pregnancy and the birth of a normal baby occurred in one of the anovulatory PCOS patient receiving an abbreviated steroid replacement protocol after ET. Immature oocyte recovery could be developed as a new method for the treatment of women with infertility due to PCO because the oocytes of these patients retain their maturational and developmental competence.
                Bookmark

                Author and article information

                Contributors
                shirasawah@doc.med.akita-u.ac.jp
                Journal
                Reprod Med Biol
                Reprod. Med. Biol
                10.1111/(ISSN)1447-0578
                RMB2
                Reproductive Medicine and Biology
                John Wiley and Sons Inc. (Hoboken )
                1445-5781
                1447-0578
                18 June 2017
                July 2017
                : 16
                : 3 ( doiID: 10.1111/rmb2.2017.16.issue-3 )
                : 258-267
                Affiliations
                [ 1 ] Department of Obstetrics and Gynecology Akita University Graduate School of Medicine Akita Japan
                Author notes
                [*] [* ] Correspondence

                Hiromitsu Shirasawa, Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine, Akita, Japan.

                Email: shirasawah@ 123456doc.med.akita-u.ac.jp

                Author information
                http://orcid.org/0000-0001-5300-0037
                Article
                RMB212042
                10.1002/rmb2.12042
                5715881
                29259476
                851e9e73-7bb0-49d0-b4fd-7e4fb0199551
                © 2017 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 14 February 2017
                : 22 May 2017
                Page count
                Figures: 1, Tables: 3, Pages: 10, Words: 8008
                Categories
                Review Article
                Review Articles
                Custom metadata
                2.0
                rmb212042
                July 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.7 mode:remove_FC converted:04.12.2017

                assisted reproductive technology,cryopreservation,fertility preservation,in vitro maturation,oncofertility

                Comments

                Comment on this article